Private Trust Co. NA Lowers Stock Position in The Clorox Company $CLX

Private Trust Co. NA reduced its stake in shares of The Clorox Company (NYSE:CLX) by 12.1% during the second quarter, Holdings Channel reports. The institutional investor owned 2,355 shares of the company’s stock after selling 325 shares during the period. Private Trust Co. NA’s holdings in Clorox were worth $283,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Clorox by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after buying an additional 65,924 shares in the last quarter. Northern Trust Corp lifted its position in shares of Clorox by 2.3% during the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after buying an additional 34,655 shares in the last quarter. Invesco Ltd. lifted its position in shares of Clorox by 7.4% during the 1st quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock valued at $200,512,000 after buying an additional 94,371 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Clorox by 3.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after buying an additional 41,485 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its position in shares of Clorox by 118.8% during the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after buying an additional 589,544 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of analyst reports. JPMorgan Chase & Co. lowered their price objective on Clorox from $135.00 to $127.00 and set a “neutral” rating on the stock in a research report on Friday, October 10th. UBS Group lowered their price target on Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. Barclays lowered their price target on Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a report on Tuesday, September 30th. Morgan Stanley lowered their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. Finally, Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus target price of $130.20.

Clorox Stock Down 0.1%

Shares of CLX opened at $119.60 on Tuesday. The stock has a market capitalization of $14.56 billion, a price-to-earnings ratio of 18.34, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The business’s 50 day simple moving average is $121.56 and its 200-day simple moving average is $127.42. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.